RTW INVESTMENTS, LP Diversified Active

CIK: 0001493215 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 15, 2017

Total Value ($000): $265,662 (100.0% shares, 0.0% debt)

Holdings (32)

Avexis Inc 15.3%
Value ($000) $40,525 Shares 849,043 Est. Cost $33.55 Unrealized
BMY Bristol Myers Squibb Co 12.4%
Value ($000) $33,070 Shares 565,888 Est. Cost $42.72 Unrealized -7.5%
ALNY Alnylam Pharmaceuticals Inc 11.1%
Value ($000) $29,548 Shares 789,208 Est. Cost $86.12 Unrealized -51.4%
BCRX Biocryst Pharmaceuticals 9.7%
Value ($000) $25,819 Shares 4,078,895 Est. Cost $7.25 Unrealized -28.2%
La Jolla Pharmaceutical Co 7.2%
Value ($000) $19,038 Shares 1,086,037 Est. Cost $25.02 Unrealized
Agenus Inc 6.5%
Value ($000) $17,346 Shares 4,210,264 Est. Cost $7.60 Unrealized
Medicines Co 4.8%
Value ($000) $12,702 Shares 374,263 Est. Cost $35.19 Unrealized
PTCT PTC Therapeutics Inc 4.1%
Value ($000) $10,879 Shares 997,166 Est. Cost $10.49 Unrealized 0.0%
INCY Incyte Corp 3.3%
Value ($000) $8,699 Shares 86,757 Est. Cost $74.63 Unrealized +30.7%
Oxford Immunotec Global PLC 3.1%
Value ($000) $8,122 Shares 543,287 Est. Cost $13.91 Unrealized
United States Oil Fund LP 3.0%
Value ($000) $7,911 Shares 675,000 Est. Cost $11.72 Unrealized
bluebird bio Inc 2.8%
Value ($000) $7,563 Shares 122,576 Est. Cost $48.74 Unrealized
Dicerna Pharmaceuticals Inc 2.2%
Value ($000) $5,884 Shares 2,043,216 Est. Cost $13.12 Unrealized
MASI Masimo Corp 2.1%
Value ($000) $5,453 Shares 80,900 Est. Cost $54.87 Unrealized +12.0%
Atara Biotherapeutics Inc 2.0%
Value ($000) $5,291 Shares 372,624 Est. Cost $14.20 Unrealized
Corium Intl Inc 1.7%
Value ($000) $4,470 Shares 1,101,045 Est. Cost $9.09 Unrealized
RGNX Regenxbio Inc 1.7%
Value ($000) $4,448 Shares 239,789 Est. Cost $24.07 Unrealized -20.6%
Viveve Med Inc 1.6%
Value ($000) $4,324 Shares 839,666 Est. Cost $4.19 Unrealized
TCMD Tactile Sys Technology Inc 1.5%
Value ($000) $4,082 Shares 248,762 Est. Cost $15.52 Unrealized +11.7%
Invuity Inc 1.0%
Value ($000) $2,616 Shares 454,900 Est. Cost $12.22 Unrealized
OMER Omeros Corp 1.0%
Value ($000) $2,570 Shares 259,039 Est. Cost $14.29 Unrealized -28.6%
Achillion Pharmaceuticals In 0.4%
Value ($000) $1,182 Shares 286,285 Est. Cost $10.21 Unrealized
Celldex Therapeutics Inc New 0.3%
Value ($000) $848 Shares 239,662 Est. Cost $12.18 Unrealized
SRTS Sensus Heatlhcare Inc 0.2%
Value ($000) $645 Shares 122,803 Est. Cost $6.26 Unrealized -6.2%
Mirati Therapeutics Inc 0.2%
Value ($000) $616 Shares 129,697 Est. Cost $33.11 Unrealized
Biopharmx Corp 0.2%
Value ($000) $476 Shares 1,273,128 Est. Cost $1.20 Unrealized
Global Blood Therapeutics In 0.1%
Value ($000) $375 Shares 25,963 Est. Cost $35.72 Unrealized
NTRA Natera Inc 0.1%
Value ($000) $371 Shares 31,693 Est. Cost $16.90 Unrealized -34.9%
Audentes Therapeutics Inc 0.1%
Value ($000) $365 Shares 20,000 Est. Cost $17.80 Unrealized
Mannkind Corp 0.1%
Value ($000) $279 Shares 438,500 Est. Cost Unrealized
Sensus Heatlhcare Inc 0.0%
Value ($000) $78 Shares 155,000 Est. Cost $0.50 Unrealized
Nivalis Therapeutics Inc 0.0%
Value ($000) $67 Shares 30,000 Est. Cost $15.17 Unrealized